Le Lézard
Classified in: Health
Subjects: RCL, CFG

Food Recall Warning - Crescent brand Pastrami and Turkey Breast - Tuscan Flavoured recalled due to Listeria monocytogenes


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/crescent-brand-pastrami-and-turkey-breast-tuscan-flavoured-recalled-due-listeria

OTTAWA, ON, Aug. 11, 2022 /CNW/ -

Summary
Affected products

Brand

Product

Size

UPC

Codes

Crescent

Pastrami

175 g 

7 78086 00255 2

22 OC 03

Crescent

Turkey Breast ? Tuscan Flavoured

175 g

7 78086 00258 3

22 SE 20

Issue

The affected products are being recalled from the marketplace due to possible Listeria monocytogenes contamination.

The recalled products have been sold in Ontario.

What you should do

Food contaminated with Listeria monocytogenes may not look or smell spoiled but can still make you sick. Symptoms can include vomiting, nausea, persistent fever, muscle aches, severe headache and neck stiffness. Pregnant women, the elderly and people with weakened immune systems are particularly at risk. Although infected pregnant women may experience only mild, flu-like symptoms, the infection can lead to premature delivery, infection of the newborn or even stillbirth. In severe cases of illness, people may die.

Learn more:

Background

This recall was triggered by the company.

There have been no reported illnesses associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...

at 05:02
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...

at 05:00
WellSync, an API-driven virtual care service provider, today announced its partnership with The Vitamin Shoppe to launch Whole Health Rx, a cutting-edge telehealth service providing access to GLP-1 medications for weight management. WellSync provides...

at 04:00
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands...

at 04:00
Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, is proud to announce the FDA clearance of...



News published on and distributed by: